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Summary.-Material with a molecular weight of less than 105 daltons has been
isolated and partially purified from the ascitic fluid of DBA2 mice bearing a syn-
geneic lymphoma (SL2). This substance inhibits the cytotoxic action of an allo-
geneic antiserum directed specifically against SL2 cells. Material has been rendered
radioactive with 1251 and between 20 and 25% of the radioactivity is bound in a
specific manner to the antiserum. The material which is referred to as 1251-TSTA
has been used in a radioimmunoassay to measure the level of TSTA in the sera
of mice bearing both ascitic and subcutaneous SL2 tumours. The level ofcirculating
TSTA was found to be high immediately following inoculation of live SL2 cells,
probably because a large proportion of the injected cells autolyse. The serum
concentration of TSTA then falls but 6-10 days later begins to rise again in parallel
with the growth of the SL2 tumour either in the peritoneal cavity or subcutaneously.
Following surgical removal of an intradermal SL2 tumour the level of TSTA in
the serum falls rapidly. No evidence could be found that a significant proportion
of the TSTA in the serum of tumour-bearing mice is completed with antibody.
However, in the serum of DBA2 mice which have been hyperimmunized with irradi-
ated SL2 cells there are antibodies which bind 1251-TSTA although syngeneic anti-
SL2 sera, unlike alloantisera, do not show complement dependent lysis of SL2
cells.
A MACROMOLECULAR substance which
neutralized a specific allogeneic antiserum
raised against the SL2 murine lymphoma
was isolated and partially purified from
the ascitic fluid of syngeneic (DBA/2)
mice bearing the tumour (Wolf and
Steele, 1975). The SL2 lymphoma arose
spontaneously in a DBA/2 mouse and
while it can be transplanted in the
syngeneic host with less than 10 cells,
resistance to it can be induced by im-
munization with irradiated cells. Com-
plement dependent cytotoxicity could
not be detected in sera from immunized
syngeneic mice but antisera raised in
C57/B1 mice to antibody (anti-DBA/2)
coated SL2 cells were lytic for SL2
cells after absorption with normal DBA/2
cells. Using this antiserum and the
purified antigen labelled with 1251, a
radioimmunoassaywasdevelopedandused
to follow antigenic activity in the sera
of mice at different stages of growth of
the SL2 lymphoma. While it has not
yet been clearly established whether this
antigenic material can induce specific
resistance in vivo to SL2 cells, the fact
that it neutralizes a lytic allogeneic
antiserum and, as shown in this paper,
combines with hyperimmune syngeneic
serum makes it likely that the material
is a tumour specific transplantation-type
antigen and we refer to it in the text
as a " TSTA ".RADIOIMMUNOASSAY OF A SPECIFIC MEMBRANE ANTIGEN
MATERIALS AND METHODS
Tumours.-The SL2 is a spontaneous
DBA/2 lymphoma (Wolf, Barfoot and
Johnson, 1972). The L5178Y, a long-
passaged lymphoma, is also syngeneic in
DBA/2 mice. Immunity can be induced
to both the SL2 and the L 5178 Y lymphoma
by immunization with irradiated cells and
there is a degree of cross resistance between
them (i.e. when immunized with 2 x 107
irradiated SL2 cells, approximately 600%
of DBA/2 animals would resist a challenge
with 103 L5178Y cells whereas 10000
would resist the same number of SL2 cells).
The TLX 9 was induced by x-rays in a
C57/B1 mouse. No serological cross-reaction
was found between this tumour and the
SL2 lymphoma (Wolf and Steele, 1975).
Soluble membrane extracts.-Papain digests
from membranes derived from SL2 cells,
TLX cells and normal DBA/2 lymphoid
cells were prepared as described by Sanderson
and Welsh (1972). They were purified by
ammonium sulphate fractionation and chro-
matography on Biogel as used for isolating
TSTA from ascitic fluid (Fig. 1).
Mleasurement of TSTA activity. Inhibi-
tion by fractionated material of the cytolytic
effect of the specific allogeneic antiserum
was used to monitor the TSTA activity
throughout the preparation procedure as
described by Wolf and Steele (1975). A
conventional complement-dependent cyto-
toxic method based upon the release of 51Cr
from specific target cells was employed
(Wigzell, 1965). The protein content of
TSTA preparations was estimated by a
modification of the Lowry method (Lowry et
al., 1951).
Murine antisera.-Details on titre and
specificity of the allogeneic anti-SL2 serum
have been published earlier (Wolf and Steele,
1975). Briefly, SL2 cells which had been
incubated together with a C57/B1 serum
containing antibodies to normal DBA/2
lymphoid tissue were injected into C57/B1
male mice. The anti-SL2 serum was ab-
sorbed with DBA/2 lymphoid cells v/v for
1 h and the absorbed serum lysed SL2
cells, but not TLX9 cells or normal DBA/2
lymphoid cells. L5178Y cells were also
lysed although at a reduced titre compared
with SL2.
Syngeneic hyperimmune serum was raised
by injecting DBA/2 male mice i.d. with
2 x 105 cells which grew to form a solid
tumour of approximately 3 mm in diameter
within 10 days. The tumours were then
excised and the animals injected at 1 month
intervals with 107 irradiated SL2 cells, the
second time together with 500 live SL2
cells. Another live inoculum of 1000 cells
was given after a further month and the
animals bled out 8-10 days later.
Rabbit anti-mouse IgG serum,.-Mouse IgG
was prepared by ammonium sulphate pre-
cipitation of normal serum of C57/B1 mice
followed by chromatography on DEAE
cellulose using conventional methods. One
to 5 mg of the resulting material was
suspended in Freund's complete adjuvant
and injected into rabbits s.c. at multiple
sites several times at monthly intervals.
After 3 months, 2 strong precipitin lines
were obtained in agar gel diffusion plates
when the serum was reacted against normal
mouse serum. When tested for cytotoxicity
against SL2 cells, the unabsorbed serum
lysed less than 10% of the cells at high
concentration and almost no cells after
absorption with SL2 cells. Figure 2 shows
that at a dilution of 1: 6 this antiserum
precipitated 80-90% 1251-mouse IgG over
a fairly wide range of concentrations covering
possible IgG concentrations in antiserum
dilutions used in the radioimmunoassay.
There was some precipitation of purified
TSTA with this antiserum, accounting for
a background of approximately 10% in the
radioimmunoassay.
Diluents.-Phosphate-buffered saline
(PBS) was prepared by adding 10% of
0-1 mol/l phosphate buffer, pH 7*4, to a
0-15 mol/l sodium chloride solution. BSA-
PBS was prepared by dissolving 50 mg
bovine serum albumin (BSA) in 10 ml
of PBS.
Labelling procedure.-In order to radio-
iodinate TSTA preparations, a modification
of the chloramine-T method of Hunter
(1974) was employed. To 25 yd antigen
solution (5-10 ,ug protein) were added 25 jul
phosphate buffer (pH 7.4, 041 mol/l), 10 ,ul
1251-sodium chromate (0.5 mCi) and 25 ,ul
chloramine-T (4 mg/ml phosphate buffer).
After 6 min of shaking, 25 ,ul of sodium
metabisulphite (12 mg/ml) and 100 ,u potas-
sium iodide (100 mg/ml), both in PBS, were
added, the latter solution containing 0-500
bovine serum albumin (BSA). The mixture
was then filtered through a Sephadex G-25
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column and labelled antigen separated from
free iodine. BSA was added to a final
concentration of10%.
Radioimrnunoassayss.-Assays were carried
out using (with slight modifications) the
double antibody method according to Egan et
al. (1972). Titrations of the specific allo-
geneic antiserum were performed in conical
polyethylene tubes (Sarstedt, 0-75 ml with
fixed lid) by adding 50 ,ul of a series of
serum dilutions in PBS to a constant amount
of labelled antigen diluted to contain ap-
proximately 25 x 103 ct/min in 10 Iul of
BSA-PBS. Another 10 I,l of BSA-PBS was
pipetted into the tubes and the mixture was
incubated overnight at 4°C. Approximately
100 yl (2 drops) of precipitating rabbit
serum diluted 1: 6 were then added and
after 5 h the tubes were centrifuged at
104 rev/min for 5 min on a cooled Misco 5500
(Microchemical Specialities Co., Berkeley,
California). The supernatant was completely
removed with a finely drawn out pipette
and the precipitate counted in a y-scintilla-
tion spectrometer (Packard, Model 3002)
without further wxNashing. The background
was determined by incubating the same
amount of labelled antigen with BSA-PBS
and precipitating serum under the same
conditions.
Inhibitory tests were performed in a
similar way except for the pre-incubation
of the unlabelled material with the diluted
specific antiserum. Ten 1l of the unlabelled
preparations were incubated 18-24 h with
a constant amount of the appropriately
diluted specific antiserum at 4°C. Ten ,ul of
labelled antigen in BSA-PBS were then
added 3-5 h before the addition of the
precipitating serum. The assay was then
continued as before.
Results from radioimmunoassays were
expressed either as percent of total counts
added (in titrations) or as the percent of
the maximal precipitable radioactivity by
theusedserum dilution(indisplacementassays
with unlabelled materials). TSTA activity
in sera from tumour-bearing animals was
expressed as inhibition, i.e.
0 inhibition=
100 - ct/min in the test precipitate xlO0 ct/min in the control precipitate
where the test precipitate involves 1251-TSTA, diluted allogeneic serum, serum from tumour-
bearing animals and precipitating serum,
and the control precipitate involves 1251
TSTA, diluted allogeneic serum, BSA-PBS
and precipitating serum. As can be seen
from Fig. 7, displacement of labelled by
unlabelled TSTA is not linearly related to
the amount of unlabelled TSTA added
(expressed as jug of protein). No attempt
was therefore made to translate inhibition
into an actual amount of TSTA. It must
be emphasized that 00 inhibition as shown in Fig. 9 and 10 reflects the change in the
amount of TSTA in serum samples but is
not directly proportional to its concentration.
RESULTS
Preparation of the TSTA for radioimmuno-
assay
The proceduire for isolating the TSTA
from the ascitic fluid of tumour-beating
mice is shown in Fig. 1 (revised procedure)
and represents a, slight variation from
the method previously described (Wolf
and Steele, 1975), in that chromatography
on DEAE cellulose was introduced earlier
in the separation procedure rather than
as the last step (original procedure).
This was done because occasionally
activity could not be eluted from the
DEAE column when the antigen was
applied in a relatively purified form.
This problem was obviated in the revised
procedure which gave betteryields but the
specific activity (Wolf and Steele, 1975) of
the final product (expressed as ,ug of
protein needed to inhibit cytotoxicity
of a specific antiserum) was not increased.
The methods used to separate antigen
from the ascitic fluid by ammonium
sulphate precipitation, chromatograph on
DEAE cellulose and Biogel were essenti-
ally as described before. The material
coming from the Biogel column in the
molecular weight range of 5 x 104 to
1.5 x 105 daltons was layered on to a
CM cellulose column (1.6 x 6 cm) and
eluted with phosphate buffer ofincreasing
ionic strength at pH 6-8. Figure 3
shows that antigen activity (as measured
by the capacity to inhibit cytotoxicitv
of a specific antiserum) appeared in
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FiG. 2. Precipitation of different amounts
of 1251-mouse IgG by 100 ytl of rabbit
anti-mouse IgG serum diluted 1: 6. The
figuires are means of dluplicates.
2 peaks. Pool 1, consisting of fractions
eluted at molarity 0-2-0*35 was selected
for radioimmunoassays and further frac-
tionation since the material in the Pool 2
fractions contained complement-blocking
factors. The protein content of Pool 1,
obtained from preparations made from
the ascitic fluid of 15 mice, was approxi-
mately 300 jtg in a total volume of
2-3 ml (approximately 0O1% of the
protein content of the starting material).
Since this material was to be used for
a radioimmunoassay which involved pre-
cipitation with a xenogeneic antiserum
to mouse IgG, the Pool 1 material was
absorbed on the rabbit anti-mouse IgG
serum which had been cross-linked with
glutaraldehyde. After centrifugation, the
supernatant was termed " TSTA-CM "
and small amounts (5-10 ,ug) were labelled
with 125J as described in Materials and
Methods. During the purification and
iodination, some of the material aggre-
gated. This was shown by passing it
through a Sephadex G-200 column, when
it was found that approximately 500o
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FRACTION (1ml)
FIG. 3.-Chromatography of Biogel fraction
5 x 104-1.5 x 105 mol. wt. (cf. revised
procedure Fig. 1) on a CM-cellulose
column (6 x 1 5 cm). Gradient started
with 0.01 mol/l phosphate buffer, pH
6-0. Gradient elution: 20 ml 0.01 mol/l
phosphate buffer, pH 6.0inrisingvessel and
20 ml of 0.5 mol/l phosphate buffer pH
850 in reservoir. ..... Gradient; ----
Protein profile at E 280; * 0 TSTA
activity measured as percent inhibition
of 51Cr-release from SL2 target cells by
specific allogeneic antiserum (Wolf and
Steele, 1975). Pool 1 was used for further
purification.
of the radioactivity eluted in fractions
corresponding to a molecular weight
greater than 105 daltons. The remainder
eluted in the 5 X 104 to 105 molecular
weight range and this was considered to
be non-aggregated antigen and is referred
to as TSTA-G2. TSTA-CM was used
in the radioimmunoassays but TSTA-G2
had to be employed to demonstrate
binding to the antiserum by chromato-
graphy (see below).
Binding of 125I-TSTA to allogeneic anti-
serum
An essential first step in the develop-
ment of a radioimmunoassay was to
show that the labelled material, which
was to be used as the antigen, bound to
the antiserum. This was established by
the technique described by Welsh and
Sanderson (1974) for transplantation anti-
gens. TSTA-G2 was incubated overnight
with different sera and then rechromato-
graphed on Sephadex G-200 columns.
Approximately 105 ct/min in 0*25 ml
were mixed with 1x25 ml of absorbed
allogeneic antiserum diluted 1 in 160.
With the alloantiserum, the profiles shown
in Fig. 4 demonstrate that 18% of the
total counts moved to a higher molecular
weight than that of the antigen itself,
IncreasingMolecular Weight
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FIG. 4.-Migration of 125I-TSTA-G2 on a
Sephadex G-200 column in the presence
of O O allogeneic immune serum;
* * syngeneic hyperimmune serum;
A A with normal DBA/2 serum.
The fraction of 1251-TSTA-G2 shifted to
a higher mol. wt. was 18% with the allo-
geneic immune serum, 11% with the
syngeneic hyperimmune serum and 7%
with the normal DBA/2 serum.
100
t -
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suggesting the formation of an immune
complex between the antigen and the
antiserum. With hyperimmune synge-
neic serum, the shift was 11% while
with normal mouse serum less than 7%
of the radioactivity was moved to a
molecular weight greater than 105 daltons.
(In a second experiment the comparative
shifts were 19% for allogeneic serum,
15% for syngeneic serum and 500 for
normal serum.) No such shift could be
demonstrated by electrophoresis on poly-
acrylamide gels (see also Welsh and
Sanderson, 1974).
Specificity of the radioimmunoassay
Titration experiments.-The details of
the radioimmunoassay are described in
Materials and Methods. The procedure
employs 2 antibodies (Egan et al.,
1972). The anti-TSTA antibody (derived
from C57/B1 mice immunized with SL2)
is reacted with 1251-labelled TSTA and
then an excess of rabbit anti-mouse IgG
is added so as to precipitate all of the
specific IgG together with the bound
125I-TSTA. Figure 5 shows titration ex-
periments in which 1251-TSTA prepara-
tions containing approximately 2 X 104
ct/min in 10 ,al were added to dilutions
of immune and control mouse sera. The
fraction of the radioactivity which was
precipitated on the addition of the rabbit
anti-mouse IgG was counted and found
to be for the allogeneic antiserum and
both TSTA-DEAE 2 and TSTA-CM be-
tween 30 and 35%o, whereas the syngeneic
hyperimmune serum precipitated ap-
proximately 28%. A background of
8-10% unspecific precipitation was noted
in these titration experiments.
Displacement experiments.-The
amount of TSTA in a specimen is calcu-
lated from the quantity of 1251-TSTA it
displaces from the precipitate which
consists of the reference amount of
1251-TSTA and the specific alloantiserum
at the optimum dilution for sensitivity,
found in our system to be 1: 250. Figure
6 shows displacement carried out with
cD
0)
I-
z
co
C)
u-i C]
LL
LLJ
tY
30
20h
>
I10_
LO
CM
1.40 1:120 1:360 1:1080 1:3240 1:9720
SERUM DILUTIONS
FIG. 5. Titrations of 4 different sera against
a constant amount of 1251-TSTA-DEAE2
or 125I-TSTA-CM respectively followed by
precipitation with rabbit anti-mouse IgG.
(a) Allogeneic antiserum and 125I-TSTA-
DEAE2; (b) allogeneic antiserum and
1251-TSTA-CM; (c) syngeneic hyperimmune
serum and 1251-TSTA-DEAE2; (d) normal
DBA/2 serum and '251-TSTA-DEAE2.
Values are the means of duplicates.
papain extracts from different cells and
Fig. 7 displacement by different TSTAs.
Materials extracted from normal DBA2
spleen cells and from the unrelated
lymphoma TLX9 (neither cells being
lysed by the absorbed specific anti-
serum) do not inhibit the binding of
1251-TSTA significantly, whereas a similar
extract from SL2 cells does. Figure 7
shows experiments with fractions 2 and 4
of the DEAE column as described earlier
(Wolf and Steele, 1975) and the prepara-
tion TSTA-CM described in this paper.
Figure 7 illustrates that the TSTA-DEAE-
2 and TSTA-CM, both ofwhich are potent
inhibitors of the cytotoxic allogeneic
antiserum, also produce significant dis-
placement in the radioimmunoassay and
that they inhibit more than TSTA-
DEAE-4 which is also relatively inactive
in the neutralization of lytic capacity.
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Fic. 6. Displacement of 1251-TSTA-DEAE2
from (louble antibody precipitate by un-
labelledt papain extracts from different
cells. A A Extract from DBA/2
lymphoid cells; A -- Extract from
TLX 9 tumour cells; * * Extract
from SL2 cells. The unlabelledi material,
at protein concen-trationis as indicated (in
BSA-PBS), was incuibated with a constant
amount of allogeieic antiserum followedc
by the addition of 1251-TSTA an(d rabbit
anti-mouse IgG serum. The values are
means of duplicates. 1000 =maximal
1251-TSTA precipitation withotit the pre-
sence of unlabelledt antigen.
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Fw4. 7. Displacement of 1251-TSTA-DEAE 2
from (louible antibody precipitate by un-
labelle(d TSTA-DEAE fractions 2 an(d 4
anlle by unlabelle(d TSTA-CMT. * 0
TSTA-DEAE 2; * * TSTA-DEAE 4;
A TSTA-CM. For (letails see
captioni of Fig. 6 andl the text.
mice and from DBA/2 mice bearing the
SL2 lymphoma were assayed to find the
most suitable dilution for the inhibition
tests described below. As can be seen
in Fig. 8, a dilution of 1 : 100 was
satisfactory.
Sera from tumour-bearing mice were
diluted 1: 100 and the percent inhibition
of binding of 1251-TSTA was determined.
Figure 9 illustrates that at Day 1 after
i.p. inoculation of the tumour a high
level of TSTA activity can be detected
in the serum. This level then declines
and reaches a minimum at Day 6, after
which it rises again and continues to
increase until the animals die, which is
approximately on DaY 14. Figure 9
further shows that when a different
preparation of 1251-TSTA was used for
assaying the same samples of animals
with an ascitic tumour the same pattern
of serum TSTA activity was observed.
An attempt was then made to deter-
mine whether part of the TSTA in the
sera of these tumour-bearing mice was
bound to antibody formed in response
to the growing tumour. The sera were
treated by a procedure which would be
expected to dissociated syngeneic anti-
TSTA activity in the serumn of tumour
bearing mice
Preliminary experiments were carried
out in which sera from normal DBA/2
Serum Dilution
FIG. 8. Displacement of 1251-TSTA-DEAE 2
from double antibody precipitate by
(lifferent (lilutions of niormal DBA/2 serum
0- 0 an(l of serum from SL2-bearing
animals * 0.
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Fic'l. 9. TSTA activity in sera of DBA/2
mice bearing ascitic SL2 cells determined
by inhibitioni of bin(ling of 1251-TSTA.
One million SL2 cells were inoculated i.p.
on Day 0. Serum samples were used
at 1 : 100 dilution. O O Tests car-
rined ouit wNith '251-TSTA-DEAE 2; * 0
tests carried ouit with 1251-TSTA-CM;
A A are values obtained with sera
that had been treated to release any
TSTA that, might be bound in antigen/
antibody complexes; for details see text.
Antigen used was 1251-TSTA-CM. The
percentage of inhibition is not, linearly
related to the amounit of TSTA (cf.
Fig. 7).
body from antigen.* Figure 9 shows
that there was no significant difference
in the capacity of lower (i.e. less than
1 05 daltons) molecular weight material
and the untreated sera to compete for
1251-TSTA. This suggests that the pro-
portion of antigen liberated into the
circulation which is bound by antibody
is small or non-existent.
Figure 10 illustrates 2 experiments
in which the level of TSTA activity was
measured in mice carrying a subcutaneous-
ly growing SL2 lymphoma. The 2 experi-
ments were carried out with 2 different
preparations of 1251-TSTA, and, as in
the case of the ascitic tumours, qualita-
tively similar results were obtained with
the 2 antigen preparations. The pattern
of TSTA activity is also similar to that
seen for the ascitic tumours, in that
immediately after inoculation high values
are found. These then drop and rise
again as the tumour grows. However,
after the growing tumour has been re-
moved surgically (which is possible since
the SL2 lymphoma does not disseminate
readily) the level of circulating TSTA
activity rapidly declines (Fig. 10).
A series of control experiments was
performed in which sera were taken from
mice bearing the unrelated TLX9 lym-
phoma which is not lysed by the allo-
antisera. At no time was any significant
TSTA activity detected in the sera, of
such mice. On the other hand, sera
from mice bearing the L 5178 Y lymphoma
showed anti-TSTA activity although this
was less than that observed with mice
bearing the SL2 lymphoma, and appears
to reflect the partial cross-reactivity
between these 2 DBA/2 tumours (cf.
Materials and Methods).
Antibody activity in the seritm of syn-
geneic mice hyperimmunized with irradiated
SL2 cells
During the course of these studies
some experiments were carried out using
syngeneic hyperimmune sera. Although
DBA/2 mice can be rendered resistant to a
challenge with SL2 cells by irradiated
SL2 cells (cf. Materials and Methods)
their sera are not cYtotoxic to SL2
cells in vitro with either weanling rabbit
or guinea-pig complement. This absence
of cytotoxicity of the hyperimmunie syn-
geneic sera is in marked contrast to the
absorbed allogeneic antiserum, which is
lytic to SL2 cells up to a titre of 1: 900
in the 51Cr release method (Wolf and
Steele, 1975). However, the hyperim-
mune syngeneic serum and the allogeneic
antiserum both bind 1251-TSTA although
the syngeneic serum binds slightly less
than the latter. Binding is shown in
* The sera were exposed to pH 3-1 and filtered through an Amicon membrane XM-100 in order to
dissilve possible immune complexes and separate material of 105 and less mol. wt. from all the higher mol. wt.
material (Thomson et al., 1973).
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DAY AFTER INOCULATION
FiG. 10. TSTA activity in sera of DBA/2 animals
carried out with 1251-TSTA-G2; 0 0 tests
carried out after tumour excision with 125I-TST.
Fig. 4 where it is determined by the
association of 1251-TSTA with a higher
molecular weight fraction than the TSTA
itself after incubation with hyperimmune
syngeneic serum and in Fig. 5 where
the degree of binding is measured in a
radioimmuno-titration assay.
DISCUSSION
The percentage of radioactivity bound
by the allogeneic antiserum indicates
that the material with the highest TSTA
activity (in terms of the capacity to
inhibit the lytic action of antibody) is
far from pure. Of the 30-3500 of the
1251-labelled material which is precipitated
with the antiserum, about 10% may
derive from non-specific background pre-
cipitation and the net value for specific
binding is close to the percent of shift
obtained in the Sephadex G-200 experi-
ment (see Fig. 4). However, since the
affinity for the 125J need not be the same
for the TSTA and the impurities, the
actual contents of TSTA cannot be
evaluated from these findings.
The material appears nevertheless suffi-
ciently pure for use in a semi-quantitative
radioimmunoassay of soluble TSTA and
indeed compares favourably with the
16 2 4 6 8 10 12 14 16
DAY AFTER EXCISION
s b
ca
A-
)earing the SL2 lymphoma s.c. 0 * Tests
Lrried out with 1251-TSTA-ClM. 0 O tests
-CM.
maximum binding activity of an antigen
used in a radioimmunoassay for HLA
antigens (Miyakawa et al., 1972). How-
ever, the procedure cannot be considered
to be a strictly quantitative assay of
circulating TSTA in the serum because
of the relatively high background and the
interference by normal serum components
(Fig. 8). But the data shown in Fig.
9 and 10 probably provide a general
representation of the changes in the level
of circulating TSTA in the serum of
mice following inoculation of SL2 lym-
phoma cells. The pattern is remarkably
similar to that found in the related
investigation from this laboratory (Thom-
son et al., 1973) in which levels of cir-
culating TSTA in the serum of rats
growing a syngeneic chemically-induced
sarcoma were followed. Immediately
after inoculation of 106 SL2 cells TSTA
appears in the blood, probably due to the
autolysis of the majority of the tumour
cells at the site of injection. The per-
sistence of circulating TSTA in the blood
both for the SL2 lymphoma and the
sarcoma appears to be only a few days
and the TSTA levels build up again as
the tumour grows. Following surgical
removal of the tumour, the circulating
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TSTA disappears from the blood within
a few days.
It is noteworthy that the procedures
used for the radioimmunoassay in this
study and in the rat sarcoma investiga-
tions were very different in that (1) the
source and the procedure used for the
isolation and purification of the TSTA
were quite dissimilar; (2) the specific
antiserum in the sarcoma experiments
was derived from syngeneic animals as
opposed to the absorbed alloantiserum
employed in the present study; (3) the
radioimmunoassay in the sarcoma studies
involved binding to insolubilized anti-
serum as opposed to precipitation by
a xenogeneic anti-mouse IgG in the SL2
experiments. That both studies showed
a similar pattern for the changes in the
blood levels of TSTA during tumour
growth gives confidence that the observ-
ations are genuine.
The present assay is not sufficiently
precise to determine whether the serum
of tumour bearing mice contains anti-
bodies that bind soluble TSTA. How-
ever, the finding that there is no signifi-
cant increase in the level of TSTA in
sera after they have been treated so as
to dissociate possible antigen-antibody
complexes indicates that at most a small
fraction of the TSTA released by the
growing tumour is complexed with anti-
body. Nonetheless, it would appear that
the DBA2 mice are capable of producing
antibodies directed against the TSTA
of SL2 lymphoma since the serum from
DBA2 mice which have been hyper-
immunized with irradiated SL2 cells
binds the 1251-TSTA isolated from the
ascitic fluid. An interesting finding is
that this hyperimmune serum does not
lyse SL2 cells in the presence of com-
plement and studies are in progress to
determine the immunoglobulin classes of
this antiserum.
This investigation has been supported
by a Programme Grant of the Medical
Research Council.
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